BIOSCIENCE IN MONTGOMERY COUNTY, MARYLAND

A NATIONALLY RECOGNIZED BIOSCIENCE CENTER

The State of Maryland and Montgomery County, in particular, have gained worldwide recognition over the last decade as a center for bioscience companies and resources. With more than 300 bioscience companies, Maryland joins California and Massachusetts as one of the nation's top bioscience centers. Moreover, more than half of Maryland's bioscience firms are located in Montgomery County, Maryland (see attached listing). In fact, Rockville and Gaithersburg, the County's largest municipalities, together boast nearly 100 bioscience firms and rank among Tech Transfer Business Magazine's top 20 cities nationwide for biotech growth. The County's bioscience industry employs more than 12,000 - this represents more than 35% of Maryland's total bioscience workforce.

MONTGOMERY COUNTY LEADS THE WAY

Montgomery County is committed to providing the best environment possible to both facilitate the expansion of our burgeoning biotech and bioscience industries and to attract additional national and international bioscience companies to the County. As a leading bioscience center, we have attained a recognized critical mass of bioscience firms representing a diversified industry base including: research laboratories; drug and product development laboratories; manufacturing facilities; and bioscience services providers.

A STRATEGIC LOCATION RICH IN RESOURCES

Montgomery County's critical mass of bioscience industries, unique federal and private infrastructure, accessible resources, and strategic location, continue to position our jurisdiction to capture a significant segment of the burgeoning bioscience industry - an industry with U.S. sales growth topping $13 billion in 1998, and projected to reach $24 billion in 2006. Montgomery County's major technology corridors are located along I-270 in the west and Route 29 near I-95 in the east, with both bioscience and information technology companies representing the core of business activity. The area's three convenient international airports provide businesses direct connections to important national and international markets and partners. The County's highly-skilled, experienced labor pool includes scientists, engineers, researchers, and other leading bioscience personnel. Eleven major universities offering advanced degree programs in bioscience, engineering, medicine, business and computer sciences are located within a fifty-mile radius of Montgomery County. Within the County, graduate, postgraduate and professional education needs are served by the University of Maryland and Johns Hopkins University, along with Montgomery College, a nationally recognized 2-year community college.

The County offers a broad choice of existing facilities as well as build-to-suit sites with outstanding proximity to top biomedical enterprises and key regulatory agencies.

The Shady Grove Life Sciences Center - This 288-acre research and development park owned and developed by Montgomery County along the famed I-270 Technology Corridor provides bioscience companies with an outstanding location. The Center is home to Human Genome Sciences, Otsuka America Pharmaceutical, BioReliance Corporation, Entremed, Life Technologies and The Institute for Genomic Research (TIGR), in addition to campuses of the University of Maryland, Johns Hopkins University and the Center for Advanced Research and Bioscience.

R&D Village - The Shady Grove Life Sciences Center is at the core of an expansive 1,200 acre research and development village. This privately developed area provides a diverse array of first class R&D and office space, hotels, housing and other facilities for the high technology industry and professional service firms.

Maryland Technology Development Center - Located adjacent to the Shady Grove Life Sciences Center, this new facility provides low cost rental space and a network of technical and business support services for emerging bioscience enterprises during the critical period of "incubation".

RESOURCES AND SUPPORT CRITICAL TO BIOSCIENCE

Montgomery County's unmatched concentration of 19 federal research and regulatory agencies attracts major bioscience companies through opportunities for contracts and R&D partnerships promoting commercial applications.

Federal Government Resources and Partnerships

National Institutes of Health (NIH) - With its 25 research institutes and the National Library of Medicine, NIH employees nearly 16,000 employees in and around its Bethesda campus. NIH is the leading biomedical research and development institute in the world.

Food and Drug Administration (FDA) - Headquartered in Montgomery County with three major research centers: Center for Biologics; Center for Drug Research and Evaluation; and Center for Devices and Radiological Health. The FDA is working closely with the bioscience industry to accelerate the regulatory review process and bring new pharmaceutical products to the marketplace.

National Institute of Standards and Technology (NIST) - The Institute plays a growing role in the advancement of bioscience research. NIST also develops many of the measurement standards necessary to facilitate the process of commercialization of the bioscience industry.

Center for Advanced Research in Biotechnology (CARB) - Located at the Shady Grove Life Sciences Center, this partnership of NIST, the University of Maryland, and Montgomery County Government provides opportunities for collaborative research projects with the bioscience industry.

Advocacy and Support Organizations

High Technology Council of Maryland and Maryland Bioscience Alliance - A membership organization representing bioscience firms, federal research laboratories, as well as educational institutions. The Council serves as a united voice for technology and bioscience, promotes educational and professional workforce development, and enhances linkages between the bioscience industry, governmental and research organizations.

Montgomery County Department of Economic Development - Develops and implements resources and services necessary to support and enhance the bioscience industry, encourages the attraction and expansion of bioscience companies to the County, and works in partnership with leaders in industry, government and support organizations to promote bioscience throughout Montgomery County.

MdBio - A private, non-profit corporation offering a variety of programs to advance the commercial development of bioscience in Maryland including: Manufacturing Incentive Programs that provide financial support to individual companies; consulting through the Business Development Program; Cost-Sharing Programs that allow companies to participate in joint efforts; Education/Workforce Development Programs designed to enhance the capabilities of today's bioscience workforce and support industry growth; and the Communications Program that provides information for and about bioscience in Maryland.

The Shady Grove Life Sciences Center

The Vision In the early 1980's, officials in Montgomery County, Maryland had the foresight that the County would quickly emerge as a hotbed for the biotechnology industry. The resources - the technology and brainpower - were already in place. Major medical advances in the areas of cancer research and gene therapy were taking place in County-based Federal agencies such as the National Institutes of Health. The thousands of scientists and researchers who had helped develop these breakthrough technologies were rapidly branching out to form their own companies. Montgomery County stood ready to assist and promote these entrepreneurs to ensure the County would become a national leader in biotechnology.

Coming to "Life"

Located in the heart of Montgomery County, the Rockville-based Shady Grove Life Sciences Center quickly became the focal point of the I-270 "Technology Corridor." Strategically located amongst an innovative biotechnology community including the National Institutes of Health, the U.S. Food and Drug Administration (FDA), and the National Institute of Standards and Technology (NIST), the concept of the Life Sciences Center soon sparked the interest of major international biotech organizations. By 1983, construction began on the new facilities for the first two biotechnology companies successfully attracted to the Center - Otsuka Pharmaceutical Company and Microbiological Associates (now known as BioReliance).

In 1985, Otsuka Pharmaceutical Company and BioReliance became the Center's first biotech tenants when they celebrated the grand opening of their brand-new headquarters and research facilities. Soon after, the educational aspect of the Center was developed with the addition of the Montgomery County Center of Johns Hopkins University and the University of Maryland's Shady Grove campus.

Expansion of the Shady Grove Life Sciences Center continued in 1988 with the development of the Key West Research Center. Located on the northeast corner of the Center, the Key West Research Center would include 225,000 square feet of Class A office and laboratory space featuring custom-finished sky-lit lobbies, loading docks, and ample free parking. The Key West Research Center was quickly 100% occupied by such major biotech firms as Human Genome Sciences and EntreMed. A new laboratory for the National Cancer Institute would also soon become a prominent feature of the Key West Research Center.

The mid to late 1990's saw the Shady Grove Life Sciences Center continue to attract and expand the impressive list of biotech tenants it features today. Among the leading tenants to join the Center's unique biotechnology network were The Institute for Genomic Research (TIGR) and Life Technologies. BioReliance, one of the Center's original tenants, also expanded during this time into two new buildings on the Center's property.

In 1998, the Maryland Technology Development Center (MTDC), a joint venture between Montgomery County and the State of Maryland, opened at the Life Sciences Center and began serving as a business "incubator" for small and start-up technology companies. The MTDC offers young companies low cost rent, short term leases, shared support services, and custom fit equipment for research and development. Just a few months after opening, the MTDC was fully occupied and a long waiting list for new tenants continues today.

The New Vision

The rapid success of the Shady Grove Life Sciences Center has led Montgomery County officials to consider the next phase of biotechnology development. The idea has received strong support of the entire biotechnology community, as companies around the world are drawn to Montgomery County's success in facilitating the industry's growth. As the demand for new biotech facilities increases, including additional labs, incubators, and research facilities, Montgomery County will continue to use the innovative concept of the Life Sciences Center to maintain the County as a leading location for biotechnology.

• 24 modular wet laboratories fully fitted with work and lab benches, sinks, and fume hoods
• A central lab equipped with autoclave available for the shared use by all tenants
• Modern infotech office spaces wired for high-speed phone, data, and internet access
• Reception, conference, private meeting and support service areas available to all tenants
• A full-sized loading dock
• Kitchen and vending areas

• Convenient location in the Shady Grove Life Sciences Center, within walking distance of major research organizations such as Johns Hopkins University and the University of Maryland
• Low cost rental space with short-term leases
• Cost effective shared services, including receptionist, fax, mail, photocopying, LCD panels, internet connection, and storage
• Business resources in professional areas such as legal matters, accounting, marketing, business plan development, and entrepreneurial training programs
• Daily management by the High Technology Council of Maryland
• Access to venture capital sources and government grants and loans such as the Montgomery County Technology Growth Fund
• Technology transfer and technical assistance from nearby federal laboratories and local universities

Genomics

Major discoveries in the field of genomics began in Montgomery County in the mid 1980's when the Human Genome Project was conceived at the Bethesda, Maryland campus of the National Institutes of Health.

What is the Human Genome Project?

The Human Genome Project (HGP) is an international research program designed to construct detailed genetic and physical maps of the human genome. The goals of the HGP are to determine the complete sequence of human DNA, to localize the estimated 50,000-100,000 genes within the human genome, and to perform similar analyses on the genomes of several other organisms used extensively in research laboratories as model systems. The scientific products of the HGP will comprise a resource of detailed information about the structure, organization and function of human DNA, information that constitutes the basic set of inherited "instructions" for the development and functioning of a human being.

Since the HGP began, a number of Montgomery County companies have emerged to become leaders in three distinct area of genomics research - Large Scale Genomic Sequencing, Bioinformatics and Applied Genomics.

Large Scale Genomic Sequencing

The race is on to determine the full genetic blueprint of a human being, and much of this effort is focused in Montgomery County, Maryland. The County is home to many innovative organizations devoted to unlocking the mystery of the human genome, including The Institute for Genomic Research (TIGR).

TIGR at a glance

Established: 1992
Location: Rockville, MD
Employees: 250
Description: TIGR is a not-for-profit research institute committed to the continued expansion of genomic sequence information and to the application of this information in medicine, agriculture, and basic biological research.
Major Accomplishments: TIGR researchers were the first to identify the estimated 60,000 to 80,000 genes contained in the human genome. TIGR's research efforts have also produced the complete genomic sequence of organisms that are the primary causes of Lyme disease, syphillis, and tuberculosis, as well as certain types of cancers and ulcers.

Bioinformatics

As the completion of large-scale genomic sequencing nears, more and more emphasis has been placed on information technology to store, analyze, and compare genomic data. Powerful computer programs and genomic databases have emerged, allowing researches to compare genetic sequences and determine their functions and relationships. Celera and Gene Logic are among the County's impressive list of globally known bioinformatics companies

Celera

Established: 1998
Location: Rockville, MD
Employees: 500
Description: Celera is the definitive source of genomic and related medical and agricultural information. Celera is undertaking the sequencing of the human genome along with a number of other biologically important model organisms. Building on the sequence data, Celera will develop and compile biological and medical data to establish the most complete life science resource available, ultimately creating the information portal for the life science and medical community.
Major Accomplishments: Celera has assembled an inter-linked array of 1200 64-bit computers designed to manage the enormous task of compiling, storing, analyzing, and delivering the genomics data they generate. This computer network provides the most DNA sequencing power in the world.

Gene Logic

Established: 1995
Location: Gaithersburg, MD
Employees: 150
Description: A leading genomics and bioinformatics company that develops proprietary information products, software, and research services and markets them to the global pharmaceutical and life science industries. The company's information products combine software tools with large-scale gene expression information. These products specify the degree to which genes are active in a broad range of normal, diseased, and treated conditions.
Major Accomplishments: Gene Logic has developed the GeneExpress database products, which profile tens of thousands of human tissue samples, animal models, and cell/tissue cultures. This information allows subscribers to identify the genes and physiological pathways associated with diseases, prioritize new drug targets for screening, and assess the potential toxicity of new therapeutic compounds.

Applied Genomics

The real payoff for the successful completion of the Human Genome Project will be the ability to use genomics to develop products to detect, treat, cure and prevent disease. In fact, the use of genomics research has already resulted in great strides in developing treatments and cures for deadly diseases such as cancer and AIDS. The impressive genetic research conducted in Montgomery County will ultimately allow humans to live longer, healthier lives. Both Human Genome Sciences, Inc. (HGS) and Digene have emerged as leaders in the area of applied genomics.

HGS

Established: 1992
Location: Rockville, MD
Employees: 500
Description: HGS is a biopharmaceutical company with the mission to discover, develop, manufacture and market new gene and protein-based drugs. HGS has pioneered the systematic study of all genes of an organism, while converting this genomic knowledge into drugs to treat and cure disease.
Major Accomplishments: HGS has successfully identified, isolated and characterized more than 1 million gene sequences, representing 95% of all human genes; HGS has also discovered the first three genomic-based drugs which are currently in human clinical studies. Two of these drugs are designed to protect the immune system from the toxic effects of chemotherapy and promote the healing of internal and external wounds. The third is designed to help grow new blood vessels in heart patients.

Digene

Established: 1985
Location: Gaithersburg, MD
Employees: 120
Description: Digene develops, manufactures, and markets proprietary DNA and RNA tests for the detection, screening, and monitoring of human diseases.
Major Accomplishments: Digene has received FDA approval to market its Hybrid Capture II HPV test in the United States, the only FDA-approved test for the detection of human papillomavirus (HPV), the cause of essentially all cervical cancer. They have also launched tests internationally for the detection and viral load monitoring of major blood viruses, including human immunodeficiency virus (HIV), cytomegalovirus (CMV) and hepatitis B virus (HBV).

• Total population: 817,000 (Most populated county in Maryland)
• Total workforce: 468,428
• 91.6% of total population hold a high school diploma
• 59.2% hold Bachelor's Degree or higher (highest concentration of advanced degree holders in Maryland)
• Average SAT scores: 1091 (Highest average in Maryland)
• Nearly 180 Bioscience and bioscience-related companies (Over 50% of Maryland's Bioscience companies)
• Over 12,000 people employed in biotech companies.

• A joint effort between the National Institute of Standards and Technology (NIST), the University of Maryland Biotechnology Institute (UMBI), and Montgomery County to create a unique forum for collaborative biotechnology research among academic, government, and industry scientists.
• A 120,000 square foot facility constructed to meet the specific needs of the biotechnology community, specifically in the field of protein structure, function, and design.
• An exceptional environment for scientists, graduate assistants, and postdoctoral fellows to further develop the critical fields of biotechnology.
• Major initiatives include narrowing the gap between discoveries in the lab and the practical needs of industry and to enhance the transfer of technology through collaborations with private companies.

• The School of Arts & Sciences
• The School of Professional Studies in Business and Education
• The School of Engineering
• The School of Public Health

• Biotechnology Laboratory Technician Program
  
• Cell Function and Morphology
• Immunology
• Nucleic Acid Analysis
• Clinical Parasitology
• Protein and Cell Techniques

Federal Agencies & Resources

The close proximity of the National Institutes of Health (NIH) was one of the major reasons the Dutch biotech company Qiagen choose to build a $40 million, 190,000 square-foot headquarters and manufacturing facility in Montgomery County. The fast-growing manufacturer of genetics research products, which was also considering locations in North Carolina and Massachusetts, ultimately selected Montgomery County to be near NIH, one of their largest clients.

Montgomery County is home to over 20 major federal research, development and regulatory agencies, many of which are directly involved in various aspects of biotechnology. The County's proximity to federal technology is a major advantage for the private sector as it provides transfer opportunities through the Small Business Innovation Research Program (SBIR), Cooperative Research and Development Agreements (CRADAs), and exclusive licensing arrangements.

In Fiscal Years 2000-2004, the Federal Government will invest over $790 million in capital facilities for the federal agencies in Montgomery County engaged in biotechnological research and regulatory activities.

Some of these new facilities have recently opened or are currently under construction at the following Federal Agencies:

National Institutes of Health (NIH)

Location: Bethesda, MD
FY 2000 Budget: $17.8 Billion
New Projects: Two new facilities are being constructed on the NIH campus. One is the 850,000 square foot Clinical Research Center that will feature 250 inpatient beds and 250,000 square feet of research laboratories. The other is the 84,600 square foot Dale and Betty Bumpers Vaccine Research Center that will be used as a center to develop an AIDS vaccine.

Food and Drug Administration (FDA)

Location: Rockville, MD
FY 2000 Budget: $1.3 Billion
New Projects: Congress has approved $35 million in the FY 2000 Budget for the first phase of FDA's new campus at the former Naval Surface Warfare Center in the White Oak section of Silver Spring, MD. The new campus will ultimately cost over $560 million. Construction is slated to begin in September 2000.

National Institute of Standards and Technology (NIST)

Location: Gaithersburg, MD
Annual Budget: Approximately $800 Million
New Projects: NIST recently dedicated a $75 million, 200,000 square foot Advanced Chemical Sciences Laboratory. This facility includes 162 laboratories that can be customized to meet a variety of needs.

Walter Reed Army Institute of Research (WRAIR)

Location: Silver Spring, MD
Annual Budget: ?
New Projects: A new $147 million, 475,000 square foot research facility recently opened on the WRAIR campus. The facility will provide research in biological and chemical technology, as well as preventative, topical, and combat casualty medicine.

Montgomery County's unmatched concentration of federal research laboratories and regulatory agencies attracts high technology companies, service industries, and vendors throughout the nation and the world. There are approximately 60,000 federal workers in Montgomery County, many of whom are engineers, scientists, and researchers involved in such federally-funded projects as the Human Genome Project (HGP). This concentration of highly skilled and specialized workers is a natural draw for rapidly growing biotechnology companies.

In fact, the impressive federal infrastructure has helped create a "critical mass mentality" for biotechnology companies in Montgomery County. Many biotech firms want direct access to the technology, talent, and funding sources found among the Federal agencies present in Montgomery County. As a result, clusters of biotech activity have been developed in the County including the Shady Grove Life Sciences Center, a 300-acre R&D park featuring major biotech organizations, healthcare facilities, and university campuses.

MONTGOMERY COUNTY'S BIOSCIENCE COMPANIES AND ORGANIZATIONS

Advanced BioResearch Associates
Advanced BioScience Laboratories, Inc.
Advanced Biotherapy Concepts, Inc.
AFC/American Fluroseal Corporation
Alpha 1 Biomedicals, Inc.
Amarex, LLC
Amba Biosciences
American Foundation for Biological Research
American Histolabs, Inc.
American Red Cross Jerome Holland Laboratory for Biomedical Sciences
Ampligene Biotechnologies, Inc.
Analytical Sciences, Inc.
Andrulis Pharmaceutical Corp.
Ani Lytics, Inc.
Anmed/Biosafe, Inc.
Antex Biologics, Inc.
Association for Entrepreneurial Science
Atlantic Biolabs, Inc.
Atto Instruments
Audiodonics, Inc.
BBI Biotech Research Laboratories, Inc.
Beecher Instruments
BioArray Technologies, Inc
Bio-Brite, Inc.
BIOCON, Inc.
BioFluids, Inc.
Bioimmunex
BioMat Sciences, Inc.
Biomed Res. and Devel. Labs Inc. (BRANDEL)
Biomedical Research Institute
Biomedical Research Instruments
Biomedical Research, Inc.
Biometrics, Inc.
Bionetics Corporation
Bioprobes, Inc.
BIOQUAL Laboratories, Inc.
BioReliance Corporation
BioSource International Inc.
Biosource Proteomics
Biotech Research Laboratories
Braton Biotech, Inc.
Buford Biomedical, Inc.
Cabtech, Inc.
Calypte Biomedical Corp.
Cambridge Biotech Corporation
Cambridge Scientific Abstracts
Capital Technology Information Services, Inc.
CardioTech International
Cary Medical Corporation
Cato Research, Limited
Celera Genomics Corporation
Cellco, Inc.
Cell Med, Inc.
Cellmark Diagnostics, Inc.
Center for Advanced Research in Biotech (CARB)
ChemGen Corporation
C.L. McIntosh & Associates
Clinical Cardiovascular Research, LLC
Coagulation Diagnostics, Inc.
Crist Instrument Company, Inc.
Cryomedical Sciences, Inc.
Dexall Biomedical Labs, Inc.
Diagnon Corporation
Diagnostic Assay Services, Inc.
Digene Corporation
DNA Technologies, Inc.
Dovetail Technologies, Inc.
DYNCORP/PRI
Edge BioSystems, Inc.
EntreMed, Inc.
ERNACO, Inc.
Exponential Biotherapies, Inc.
EXOTECH, Inc.
FAST Systems, Inc.
Fertile Hemispheres, Inc.
Fidelity Systems, Inc.
Fortune Biologicals, Inc.
Futrex, Inc.
Galenica Pharmaceuticals, Inc.
Gene Logic, Inc.
GeneDX
GenePrime, Inc.
Genetic Therapy, Inc.
Genome Dynamics, Inc.
GenoQuest, Inc.
GenVec, Inc.
Genzyme/TSI Washington
GEO-CENTERS, INC.
Gillette Medical Evaluation Labs
GlycoTech Corporation
GP Environmental Services, Inc.
Hemispherx Biopharma, Inc.
Henry M. Jackson Foundation for the Advancement of Military Medicine
Howard Hughes Medical Institute
HT Medical Systems, Inc.
Human Genome Sciences, Inc.
HYPERTEK
IGEN International, Inc.
Immuno-OncoGenomics, Inc.
Imperium, Inc.
Industrial Quality, Inc.
InforMax, Inc.
Innovative Medical Services, Inc.
Institute for In Vitro Sciences
Integrated Biomedical Services
Intergen Company
International TLB Research Institute, Inc.
Intracel Corporation
Irradiation Industries, Inc.
Intron Holdings, LLC
KamTek, Inc.
Kirkegaard and Perry Laboratories, Inc.
Kolodny Research, Inc.
L.A.O. Enterprises, Inc.
Lab Products
Large Scale Biology Corporation
Lewis Medical Instruments
Life Technologies, Inc.
LKC Technologies, Inc.
Loftstrand Labs Limited
LT Industries
Mankind Research Foundation
Marvin E. Lasser, Inc.
McKesson HBOC
Mechanics and Materials Science
MedImmune, Inc.
Mid-Atlantic Bio-Research Corp.
Molecular Histology Laboratory, Inc.
NABI
NeighborCare, Inc.
Neuro Probe, Inc.
Neurologic, Inc.
Neurotrophic Research Corporation
Neutron Products, Inc.
New Drug Services International, Inc.
Nicholson Precision Instruments
Nissei Sangyo America, Ltd./Hitachi Scientific Instruments
Novavax, Inc.
NPD, LLP
Nymox Pharmaceutical Corp.
O.S.E. Company
Oncoimmunin, Incorporated
OriGene Technologies, Inc.
Otsuka America Pharmaceutical, Inc.
Pacific Scientific Company HIAC/ Royco Division
Panacea Pharmaceuticals, Inc
PEM Technologies, Inc.
Peptide Technologies Corporation
Pharming Healthcare, Inc.
PLA
Poietic Technologies, Inc.
Point of Care Technologies
Polychem, Inc.
Potomac Medical Systems
Primedica Corporation
Prometic Biosciences (USA), Inc.
Pro-Neuron, Inc
Prospect Associates, Limited
Proteinix Company
Protiveris, Inc.
Providence Laboratory Associates
Pro-Virus, Inc.
Quality Biological, Inc.
Quintiles BRI, Inc.
Radiation Technology, Inc.
Rheotech Labs, Inc.
Roboz Surgical Instrument Company, Inc.
Roveko, Ltd.
Sage Diagnostics, Inc.
Sensors for Medicine and Science, Inc.
Shire Laboratories Inc.
SHS North America
Sigma-Tau Pharmaceuticals, Inc.
Sitek Research Laboratories
Social & Scientific Systems, Inc.
Spiral Biotech, Inc.
SRA Life Sciences, Inc.
StaphRx, LLC
SuperArray, Inc.
Supertechs, Inc.
Technical Resources International, Inc.
Tetracore, LLC
The EMMES Corporation
The Institute for Genomic Research (TIGR)
TheraMed, Inc.
Therapeutic Genomics, Inc.
TherImmune Research Corporation
Tissue Engineering Sciences
TouchStone Research, LLC
Tracor Systems Technologies, Inc.
Trevigen, Inc.
United States Pharmacopiea
United Therapeutics Corp
Universal Biotechnology, Inc.
Veritas, Inc.
Virion Systems, Inc.
Virotech International, Inc.
VIRXSYS
VRG International
Wallac, Inc.
Washington Laboratories
Westat, Inc.
Zone Therapeutics, Inc.

With the Shady Grove Life Sciences Center at its core, Montgomery County's Research and Development Village is dedicated to supporting high tech industries, institutions, and their employees. Private developers are providing first class R&D and office space, housing, hotel and other support services within the 1,200 acre area.